David S. Hewings

1.3k total citations
16 papers, 899 citations indexed

About

David S. Hewings is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, David S. Hewings has authored 16 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Hematology. Recurrent topics in David S. Hewings's work include Protein Degradation and Inhibitors (10 papers), Multiple Myeloma Research and Treatments (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). David S. Hewings is often cited by papers focused on Protein Degradation and Inhibitors (10 papers), Multiple Myeloma Research and Treatments (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). David S. Hewings collaborates with scholars based in United Kingdom, United States and France. David S. Hewings's co-authors include Stuart J. Conway, Stefan Knapp, John A. Flygare, Matthew Bogyo, Ingrid E. Wertz, Timothy P. C. Rooney, Paul E. Brennan, O. Fedorov, P. Filippakopoulos and S. Picaud and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Nature Chemistry.

In The Last Decade

David S. Hewings

16 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David S. Hewings United Kingdom 11 768 300 180 168 51 16 899
Duncan A. Hay United Kingdom 12 705 0.9× 310 1.0× 194 1.1× 122 0.7× 20 0.4× 18 938
Timothy P. C. Rooney United Kingdom 9 600 0.8× 252 0.8× 103 0.6× 117 0.7× 21 0.4× 13 687
Maria Mangos Canada 7 1.4k 1.8× 399 1.3× 45 0.3× 155 0.9× 39 0.8× 12 1.5k
Hannah Lingard United Kingdom 7 454 0.6× 206 0.7× 98 0.5× 79 0.5× 14 0.3× 8 552
Benjamin P. Martin United States 15 716 0.9× 204 0.7× 109 0.6× 269 1.6× 92 1.8× 19 989
Darryl B. McConnell Austria 17 508 0.7× 63 0.2× 277 1.5× 148 0.9× 68 1.3× 47 861
Wenzhang Chen China 11 1.1k 1.5× 298 1.0× 62 0.3× 441 2.6× 14 0.3× 19 1.2k
Andrew B. Benowitz United States 13 509 0.7× 98 0.3× 187 1.0× 207 1.2× 83 1.6× 22 714
Nicholas A. Eleuteri United States 9 630 0.8× 136 0.5× 42 0.2× 250 1.5× 22 0.4× 9 691

Countries citing papers authored by David S. Hewings

Since Specialization
Citations

This map shows the geographic impact of David S. Hewings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Hewings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Hewings more than expected).

Fields of papers citing papers by David S. Hewings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Hewings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Hewings. The network helps show where David S. Hewings may publish in the future.

Co-authorship network of co-authors of David S. Hewings

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Hewings. A scholar is included among the top collaborators of David S. Hewings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Hewings. David S. Hewings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bineva‐Todd, Ganka, et al.. (2024). Expanding the repertoire of GalNAc analogues for cell-specific bioorthogonal tagging of glycoproteins. RSC Chemical Biology. 5(10). 1002–1009. 2 indexed citations
2.
Chan, Anthony, David S. Hewings, Matthias Schiedel, et al.. (2020). Fragment-Based Identification of Ligands for Bromodomain-Containing Factor 3 of Trypanosoma cruzi. ACS Infectious Diseases. 7(8). 2238–2249. 10 indexed citations
3.
Hewings, David S., Johanna Heideker, P. Taylur, et al.. (2018). Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. Nature Communications. 9(1). 1162–1162. 71 indexed citations
4.
Hewings, David S., John A. Flygare, Matthew Bogyo, & Ingrid E. Wertz. (2017). Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights. FEBS Journal. 284(10). 1555–1576. 94 indexed citations
5.
Hewings, David S., John A. Flygare, Ingrid E. Wertz, & Matthew Bogyo. (2017). Activity‐based probes for the multicatalytic proteasome. FEBS Journal. 284(10). 1540–1554. 30 indexed citations
6.
Hewings, David S., et al.. (2016). Isoxazole‐Derived Amino Acids are Bromodomain‐Binding Acetyl‐Lysine Mimics: Incorporation into Histone H4 Peptides and Histone H3. Angewandte Chemie International Edition. 55(29). 8353–8357. 18 indexed citations
7.
Hewings, David S., et al.. (2016). Isoxazole‐Derived Amino Acids are Bromodomain‐Binding Acetyl‐Lysine Mimics: Incorporation into Histone H4 Peptides and Histone H3. Angewandte Chemie. 128(29). 8493–8497. 5 indexed citations
8.
Karmakar, Saswata, Emily M. Harcourt, David S. Hewings, et al.. (2015). Organocatalytic removal of formaldehyde adducts from RNA and DNA bases. Nature Chemistry. 7(9). 752–758. 37 indexed citations
9.
Brand, Michael, Brian G. Wilson, Wilian A. Cortopassi, et al.. (2014). Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions. ACS Chemical Biology. 10(1). 22–39. 132 indexed citations
10.
Cresswell, Alexander J., Stephen G. Davies, David S. Hewings, et al.. (2013). Synthesis and Crystal Structures of N-Aryl-N-methylaminocyclohexanols. Journal of Chemical Crystallography. 43(12). 646–654. 4 indexed citations
11.
Davies, Stephen G., David S. Hewings, W. Kurosawa, et al.. (2013). Synthesis and Crystal Structures of (RS,RS,RS)- and (1RS,2RS,3SR)-3-(N-Methylamino)cyclohexane-1,2-diol. Journal of Chemical Crystallography. 44(1). 30–35. 2 indexed citations
12.
Hewings, David S., O. Fedorov, P. Filippakopoulos, et al.. (2013). Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands. Journal of Medicinal Chemistry. 56(8). 3217–3227. 103 indexed citations
13.
Hewings, David S., Timothy P. C. Rooney, Duncan A. Hay, et al.. (2012). Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions. Journal of Medicinal Chemistry. 55(22). 9393–9413. 136 indexed citations
14.
Hay, Duncan A., O. Fedorov, P. Filippakopoulos, et al.. (2012). The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains. MedChemComm. 4(1). 140–144. 54 indexed citations
15.
Claridge, Timothy D. W., Richard G. Compton, Stephen G. Davies, et al.. (2012). Ammonium-Directed Olefinic Epoxidation: Kinetic and Mechanistic Insights. The Journal of Organic Chemistry. 77(17). 7241–7261. 29 indexed citations
16.
Hewings, David S., Minghua Wang, Martin Philpott, et al.. (2011). 3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands. Journal of Medicinal Chemistry. 54(19). 6761–6770. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026